Resilia Revenue and Competitors

Location

$10.4M

Total Funding

Estimated Revenue & Valuation

  • Resilia's estimated annual revenue is currently $9.3M per year.(i)
  • Resilia's estimated revenue per employee is $126,150
  • Resilia's total funding is $10.4M.

Employee Data

  • Resilia has 74 Employees.(i)
  • Resilia grew their employee count by -27% last year.

Resilia's People

NameTitleEmail/Phone
1
President & CEOReveal Email/Phone
2
CTOReveal Email/Phone
3
VP EngineeringReveal Email/Phone
4
SVP RevenueReveal Email/Phone
5
Head OperationsReveal Email/Phone
6
Director DesignReveal Email/Phone
7
Senior Director Institutional PartnershipsReveal Email/Phone
8
Senior Director Institutional PartnershipsReveal Email/Phone
9
Senior Director Institutional Partnerships, EquityReveal Email/Phone
10
Senior Director Institutional PartnershipsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1.2M1417%N/AN/A
#2
$22.5M141N/AN/AN/A
#3
$2.3M235%N/AN/A
#4
$0.6M80%N/AN/A
#5
$0.7M9N/AN/AN/A
#6
$0.1M20%N/AN/A
#7
$7.7M59N/AN/AN/A
#8
$0.9M100%N/AN/A
#9
$2.5M2532%N/AN/A
#10
$1.2M140%N/AN/A
Add Company

What Is Resilia?

Resilia is a fast-growing, venture-backed, mission-driven SaaS tech startup with offices in NYC and New Orleans. Resilia's SaaS products help nonprofit organizations become high-performing and enable Enterprises (corporations, cities, and private foundations) to measure and scale the impact of their grant deployments. Our mission is to harness the power of generosity, technology, and human connection to make nonprofit leadership available for everyone.

keywords:saas

$10.4M

Total Funding

74

Number of Employees

$9.3M

Revenue (est)

-27%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Resilia News

2022-04-06 - Herd Immunity Out of Reach? House Caps Insulin $$; First ...

Edwards Lifesciences announced FDA approval of Mitris Resilia, a bovine tissue valve replacement for mitral replacement surgeries.

2022-03-30 - EDWARDS MITRIS RESILIA VALVE RECEIVES FDA ...

RESILIA tissue is bovine pericardial tissue and serves as the platform for Edwards' new class of valves. RESILIA tissue has been studied in two...

2022-03-22 - Here's Why You Should Retain Edwards Lifesciences (EW) Now

The growing uptake of Edwards RESILIA tissue valves is another upside. ... including INSPIRIS RESILIA aortic valve, the KONECT RESILIA...

2021-02-17 - Resilia Hires Ash Didwania as SVP of Revenue to Accelerate Growth and Further Company Vision

NEW ORLEANS, Feb. 17, 2021 /PRNewswire/ -- This week, social impact-focused SaaS company Resilia officially announced the addition of experienced tech and revenue leader, Ash Didwania, to the executive team. After spending 12 years in enterprise sales and management roles at both social good s ...

2020-05-12 - Resilia Raises $8M in Series A Funding

Sevetri M. Wilson, founder and CEO at Resilia (Photo: Business Wire) Resilia, a New Orleans, Louisiana-based provider of a SaaS platform for nonprofits, raised $8M in series A funding. The round was led by Mucker Capital and Callais Capital Management with participation from Cultivation Capita ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$14M7435%N/A
#2
$16.8M74N/AN/A
#3
$12.2M759%N/A
#4
$13.8M756%N/A
#5
$20.5M767%N/A